During the past decade, Health Strategy and Policy Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Health Strategy and Policy Institute" #1 collaborator was "Baylor Research Institute" with 1 trials as a collaborator, "Health Strategy and Policy Institute" with 1 trials as a collaborator, "HelpAge International" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Thai Nguyễn University of Medicine and Pharmacy" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Health Strategy and Policy Institute" are "Hypertension" (2 trials), "Cardiovascular Diseases" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Health Strategy and Policy Institute" in a lesser frequency.

Most popular intervention types in "Health Strategy and Policy Institute" are "Behavioral" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Expanded community health worker services" (1 trials), "Home blood pressure self-monitoring" (1 trials), "Storytelling intervention" (1 trials), "Vietnam National Hypertension Program" (1 trials) and "screening, prevention and counselling" (1 trials). Other intervention names were less common.

The vast majority of trials in "Health Strategy and Policy Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Health Strategy and Policy Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Health Strategy and Policy Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Health Strategy and Policy Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".